Durham-based Priovant Therapeutics, with Roivant Sciences, has shared encouraging results from its Phase 3 VALOR study evaluating brepocitinib, a potential new treatment for the autoimmune disease ...

Novonesis, a global leader in biosolutions, welcomed hundreds of local students, educators, and community leaders to its ...

Novonesis, a global leader in biosolutions, welcomed hundreds of local students, educators, and community leaders to its ...

“We're all familiar with the cost-price squeeze in agriculture,” he said. “Our cost of production and output prices are ...

Join BTEC for a lunch and learn on Oct. 24. Discover how sbi is transforming shake flask experiments with real-time DO, biomass, and fluorescence monitoring — bringing clarity, control, and confidence ...

Oxford-based Plantd has raised $22 million in venture capital to advance its production of carbon-negative building materials ...

Parexel, a clinical research organization (CRO) providing clinical and consulting solutions to the life sciences industry, has opened its new global headquarters in Raleigh’s North Hills Innovation ...

The Quantra Hemostasis System is a cartridge-based viscoelastic testing system that uses a proprietary ultrasound technology ...

Now North Carolina newcomer OXB, a UK-based CDMO in cell and gene therapy, announced Oct.7 that it has acquired the former ...

There is no cure yet for OA of the knee. Short-term measures such as oral pain medications, physical therapy or steroid injections into the knee can provide short-term relief. There are only a handful ...

Durham-based BioCryst Pharmaceuticals Inc. plans to acquire Boston-based Astria Therapeutics Inc., adding the late-stage hereditary angioedema (HAE) treatment, navenibart, to its portfolio. The ...

Hear directly from UNC faculty who’ve successfully navigated the commercialization process through startups, licensing, or industry partnerships. This engaging discussion will offer practical insights ...